The CAGR of the North America Home Insemination Products Market is estimated to be 8.6% during the forecast period (2022 - 2027).
The North American market is estimated to grow due to key driving factors like growing support from government authorities in approving the latest technological developments and rising infertility problems among men and women associated with lifestyle changes.
In August 2019, Hamilton Throne acquired Planer Ltd to develop research. This acquisition enhances the product offerings in cryopreservation, incubation, and lab monitoring solutions and focuses on decreasing cost, increase productivity and improve results.
In September 2020, MedGyn acquired Thomas Medical. This will allow MedGyn to concentrate on domestic manufacturing and distribution globally while providing customers access to Thomas Medical’s product portfolio.
Market Drivers and Restraints:
Infertility is common in developed countries. In the United States, out of 100 couples, about 12 to 13 of the couples have trouble becoming pregnant. About 10 out of 100 (6.1 million) women in the U.S. aged 26–40 years have difficulty becoming pregnant or staying pregnant, based on the Centres for Disease Control and Prevention. Hence, women are opting more for home insemination, which provides privacy and ease. As a result, the key medical organizations are keen on investing more towards Home Insemination products, and this is expected to drive the North American home insemination market growth during the forecast period (2022 - 2027).
Stringent government laws and rising concern towards safety are set to hamper the expansion of the North American home Insemination market. There is a high possibility of a woman giving birth to twins or triplets is hampering the expansion of the home Insemination Market over the forecast period. The market is predicted to experience slow growth during the conjecture period due to expensive procedures of reproductive techniques.
The home insemination market based on procedure has been segmented into intracervical insemination, intrauterine insemination, and intratubal insemination. The intrauterine insemination sub-segment is to lead the dominant shares of the market. Rising investments in the improvement of healthcare are leveling up the demand of the market.
The home insemination market, by product type, has been divided into home conception devices, insemination kits, and accessories. Among these, the insemination kits segment is estimated to be the fastest-growing segment in terms of value because of the growing geriatric population and is predicted to generate higher revenue during the foreseen period
The home insemination market, based on end-user, has been classified into fertility centers, hospitals and clinics, home care settings, and others. The fertility centers segment is estimated to carry the largest share of the regional market during the forecast period. Focus on the development of new innovative kits in favor of the end-user is likely to flourish the growth rate of this segment.
The recent outbreak of the Coronavirus has turned the spotlight on the healthcare industry and subsequently affected the Home Insemination market. Severe shortages of critical medical supplies and a rapid increase in the number of COVID-19 cases have resulted in a revolution and thus affected the evolution in the healthcare ecosystems. Following government measures, particularly stay-at-home orders, and social distancing norms, doctors are postponed preventing the spread of Coronavirus. Further, supply chain disruptions and movement restrictions have created a logistical nightmare for market players, resulting in severe product shortages in the global marketplace.
Geographically, North America (including the USA and Canada) accounts for a significant share in the market for home insemination due to the major demand from the United States market. The demand for home insemination kits in the United States is gearing up for the past few years owing to increasing disposable income. North America dominated the home Insemination Market in 2020 with a share of over 41.02%. This is because of the growing demand for Home Insemination by single mothers & lesbian couples and the increasing prevalence of infertility among adults. Technological advancements, favorable rules and regulations, and increasing health sector and private sector investments are factors expanding the growth rate of the home Insemination Market in North America.
Some of the key players operating in the artificial insemination market are Rocket Medical plc, INVO Bioscience, Medgyn Products, Inc., Kitazato Corporation, Fujifilm Irvine Scientific., Genea Limited, Rinovum Women's Health, LLC., Vitrolife, and Hi-Tech Solutions.
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Home Insemination Products Market, By Procedure
6.1.1 Intrauterine Insemination
6.1.2 Intracervical Insemination
6.1.3 Intratubal Insemination
6.1.4 Market Size Estimations & Forecasts (2022 - 2027)
6.1.5 Y-o-Y Growth Rate Analysis
6.1.6 Market Attractiveness Index
6.2 Home Insemination Products Market, By Product Type
6.2.1 Insemination Kits
6.2.2 Home Conception Devices
6.2.4 Market Size Estimations & Forecasts (2022 - 2027)
6.2.5 Y-o-Y Growth Rate Analysis
6.2.6 Market Attractiveness Index
6.3 Home Insemination Products Market, By End-User
6.3.1 Hospital & Clinics
6.3.2 Fertility Centers
6.3.3 Home Care Settings
6.3.4 Market Size Estimations & Forecasts (2022 - 2027)
6.3.5 Y-o-Y Growth Rate Analysis
6.3.6 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2021- 2027)
7.2.1 By Country
7.2.2 By Procedure
7.2.3 By Product Type
7.2.4 By End-User
7.3.1 By Country
126.96.36.199 Rest of Europe
7.3.2 By Procedure
7.3.3 By Product Type
7.3.4 By End-User
7.4 Asia Pacific
7.4.1 By Country
188.8.131.52 South Korea
184.108.40.206 South East Asia
220.127.116.11 Australia & NZ
18.104.22.168 Rest of Asia-Pacific
7.4.2 By Procedure
7.4.3 By Product Type
7.4.4 By End-User
7.5 Latin America
7.5.1 By Country
22.214.171.124 Rest of Latin America
7.5.2 By Procedure
7.5.3 By Product Type
7.5.4 By End-User
7.6 Middle East and Africa
7.6.1 By Country
126.96.36.199 Middle East
7.6.2 By Procedure
7.6.3 By Product Type
7.6.4 By End-User
8. Key Player Analysis
8.1 INVO Bioscience
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Medgyn Products, Inc.
8.3 Fujifilm Irvine Scientific
8.4 Kitazato Corporation
8.5 Rocket Medical plc
8.6 Genea Limited
8.8 Rinovum Women's Health, LLC
8.9 HI-TECH Solutions
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.